(Adds: Revance Therapeutics, Enterprise Bancorp, Novolex,
Arthur J Gallagher, Dow Updates: Omnicom Group)
Dec 9 (Reuters) - The following bids, mergers,
acquisitions and disposals were reported by 1430 GMT on Monday:
** Anti-wrinkle injection maker Revance Therapeutics
RVNC.O has agreed to be bought for $3.10 per share by
privately held Crown Laboratories, instead of the $6.66 per
share agreed previously, the two companies said.
urn:newsml:reuters.com:*:nL4N3NA111
** Enterprise Bancorp EBTC.O and Independent Bank
INDB.O , the parent of Rockland Trust, have agreed to merge in
a cash-and-stock deal valued at $562 million, they said, as
regional lenders continue to consolidate their operations.
urn:newsml:reuters.com:*:nL4N3NA0XU
** Apollo Global Management-owned APO.N Novolex will
buy packaging products maker Pactiv Evergreen PTVE.O in a $6.7
billion deal, the companies said.
urn:newsml:reuters.com:*:nL4N3NA0Y0
** Arthur J Gallagher AJG.N said it would acquire
insurance broker AssuredPartners in an all-cash deal worth
$13.45 billion, as it looks to bolster its focus on property and
casualty and employee benefits across the U.S.
urn:newsml:reuters.com:*:nL4N3NA0NX
** Omnicom Group OMC.N has struck a $13.25 billion
all-stock deal to buy rival Interpublic Group IPG.N , creating
the world's largest advertising agency as traditional players
look to better compete with Big Tech firms amid accelerating use
of AI.
urn:newsml:reuters.com:*:nL4N3NA0TP
** Dow DOW.N said it would sell a 40% stake in some
U.S. Gulf Coast infrastructure assets to a fund managed by
Macquarie Asset Management for $2.4 billion as it looks to focus
more on its core chemicals business.
urn:newsml:reuters.com:*:nL4N3NA0O5
** Nature Infrastructure Capital and Davidson Kempner
Capital Management said that they had jointly acquired the
Dutch-based solar power and storage project development platform
of Greencells Group.
urn:newsml:reuters.com:*:nS8N3LX03N
(Compiled by Rajarshi Roy and Kamal Choudhury in Bengaluru)
((Rajarshi.Roy@thomsonreuters.com;))